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ScienDific Name 
Scorpeona porcus 
Scorpeona scrota 
MaUese 
Scorf.na sewda 
Cippulazza 
English 
Small scaled 
scorpion-fish 
Largescaled 
scorpion-fish 
ItaLian 
Scorfano nero 
Scorfano rosso 
81 
HeLicoLenus dactyLopterus Skorfna tal-ghajn Rock-fish Scorfano di 
fondal'e 
Dasyatis p'astimaca 
Dasyatis vioLacea 
BoIl 
Bo1l tork 
This is by no means a full ,list. My 
advice to amateur harpoonists and sub~ 
aqua enthusiasts is to make sure that they 
know their fish carefully before handling 
the prized catch. 
Commo!! string-ray. Pastinaca 
Blue sting-ray Trigone viola 
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Historical outline 
Asthma has attracted a great deal of 
attention over the centuries probably 
because its clinical manifestations of 
breathlessness and wheezing present them-
selves in such a dramatic manner. The 
word asthma is deriv,ed directly from the 
Greek asthma - meaning a hard drawn 
breath or panting. The first clinical 
description is attributed to Aretaeus the 
Cappadocian who, emphasizing the plight 
of the asthmatic patient, wrote: 'they 
eagerly go into the open air, since no 
house sufficeth for their respiration'. 
In the early 17th century, van 
Helmont, himself an asthmatic, provided us 
with what is thought to be the first refer-
ence of allergy being involved in the aetiol-
ogy of asthma. He has given us a vivid 
description of a monk who had attacks, 'as 
oft as any place is swept, or the Wind doth 
otherwise stir up the Dust'. This poor 
monk must have had quite a rough time, 
especially on Fridays, for van Helmont aclso 
describes him as having attacks when "he 
eateth Fishes fried with Oyl'. To van 
Helmont should be given the credit for 
being the first to point out that asthma re-
sulted from "a drawing together of the 
smallest terminal bronchi" an observation 
which has given rise to endless controversy 
ever since. We owe the modern concept 
of asthma to T. Willis, perhaps better 
remembered for his famous circle. Willis, 
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says of asthma, 'there is scarce anything 
more sharp or terrible than the fits there-
of'. He describes two forms of asthma; 
pneumonic and convulsive; he associated 
the former with "obstruction of the 
bronchi by thick humors, swelling of their 
walls and obstruction from without" and 
believed convulsive asthma to be due "to 
cramps of the moving fibres of the bronchi'. 
In 1698, Sir John Floyer, who like van 
Helinont was an asthmatic, published his 
classical book on asthma. He adopted 
Willis's classification, calling convulsive 
asthma: periodic, and pneumonic asthma: 
continued, and assigned as a cause for the 
paroxysms "a contracture of the muscular 
fibres of the bronchi". 
For a long time asthma was considered 
to be a disease of moderate morbidity and 
negligible mortality. Indeed, Oliver 
WendellHolmes, is quoted in OsIer's book 
as calling asthma "the slight ailment that 
promotes longevity" and the French physi-
cian Armand' Trousseau called it "le brevet 
de longue vie". Until Huber & Koess]e::'s 
paper in 1922, it had been claimed that 
death did not occur in the asthmatic 
paroxysm. Although the dangers of asthma 
are now fully appreciated, it is disturbing 
to come across statements in the literature 
such as "Bronchial asthma alone rarely 
causes death. When it does prove fatal 
it is due either to the concufl'ent bronchitis 
and bronchiolitis or to heart failure". 
(Spencer, 1968). 
Between 1959 and 1966 a steady rise 
in mortality from asthma was observed in 
England and Wales, the increase being 
more pronounced between ages 5 - 34 
years. Speizer and his co-workers (1968) 
showed that the rise was real and not due 
to a change in diagnostic methods or regis-
tration of cause' of death. They subsequent-
ly examined the pOSSIble reasons and con-
cluded that the increase in mortality was 
most likely to be due to changes in treat-
ment. Sympathomimetic aerosols and 
corticosteroids were the only drugs to have 
been used by a large proportion of the 
patients who died. The use of corticos-
teroids, which had been introduced in 1951, 
did not seem to be related to the cause of 
death, and sympathomimetic aerosols, in-
troduced in 1961, were incriminated. Fol-
lowing the puhlicity given to the possible 
dangers of excessive inhalation, there was 
a drop in sales which has been paralleled 
by a downward trend in the reported 
numbel" of deaths due to asthma (Fraser 
et aL, 1971). 
Several mechanisms whereby 
sympathomimetic aerosols might be res-
ponsible for the increase in the asthma 
death' rate have been suggested. The in-
duction of fatal cardiac arrythmias by 
sympathomimetic drugs, especially in the 
hypoxic state, is one of the explanations 
given by a number of workers, amongst 
whom Lockett (1965); Greerrberg & Pines 
(1967) and CoUins et aL, (1969). Bass, in 
1970 blamed the fluol'ocarbons, used as 
propeUent agents in the aerosols, for pro-
ducing arrythmias. More recently, Conolly 
and his co-workers (1971), have claimed 
that prolonged administration of these 
bronchodilators might result in resistance 
being developed not only to the sympatho-
mimetic drugs themselves but also to 
endogenous sympathetic stimulation. They 
suggest that this could have led to the 
deterioration, and finally to death, in 
asthmatic patients using sympathomimetic 
aerosols. 
Aetiology and Pathogenesis 
Asthma, which may best be regarded 
as a complex functional state which can be 
triggered off by a wide variety of agents, 
still presents a great number of difficult 
problems and there are far more questions 
to be asked than answel'S to be given. 
Although there have been several attempts 
at defining this condition - Ciba Guest 
Symposium 1959; American Thoracic 
Society, 1962; Scadding, 1969 - there is 
still no, agreement between clinicians, res-
piratory physiologists, immunologists and 
pharmacologists on a final definition, as 
evidenced by a report' of the Working 
Group on the Definition of Asthma, 
published in 1971. 
The aetiology and precise pathogenesis 
of bronchial asthma are still uncertain al-
though a great deal of evidence is now 
forthcoming about the various factors that 
are capable of triggering off an attack. The 
relative importance of a genetic predis-
position, enviromental allergens, im,-
munological mechanisms, infection and 
emotional factors, in determining the dif-
ferent patterns of the disease is far from 
clear. 
(i) Hereditary factors. 
As eal'ly a3 1916 Cooke and Van der 
Veer stressed the hereditary nature of 
allergic diseases. WiHiams and Williams in 
1949 found that about 50% of the asthma-
tic patients gave a history of allergy in 
close relatives. Leigh and Marley in 1967 
found that about 40% of first degree 
relatives of patients with asthma developed 
the disease by the age of 65 years. Rajka 
(1960) pointed out that what may be in-
herited is not the allergic manifestation 
but the allergic disposition. Although it 
has been suggested that atopy is deter-
mined by a single, autosomal, dominant 
gene with reduced penetrance, the exact 
genetic factor and the mode of inheritance 
are still far from certain, and although the 
clinical evidence of inheritance of atopic 
diseases is often very suggestive, the 
evidence is not as conclusive as it is some-
times made out to be. 
(ii) Immunological aspects. 
Bronchial asthma is often very broad-
ly classified into two major sub-divisions, 
'extrinsic' and 'intrinsic'. In extrinsic 
asthma, an external allergen can be de-
monstrated, the age of onset is usually 
early and a Type I (Gell and Coombs, 
1968) immediate allergic reaction is gener-
aHy the cause. The term intrinsic asthma 
was applied by Rackemann in 1947 to des-
cribe a group of patients in whom no 
external allergen could be shown (prick 
tests being negative to a wide range of 
antigens) and whose symptoms begin in 
adult life. 
The type of hypersensitivity most 
commonly encountered in extrinsic asthma 
is that due to a Type I immediate reaction. 
In Type I 'allergy the antibody responsible 
for mediating the release of pharmacolo-
gical factors responsible for this kind of 
asthma was originally termed "reagin" by 
Coca and Grove in 1925. Reagin has recent-
ly been shown to belong to a separate class 
of immunogolobulin (Ishizaka et aL, 19,66; 
Johansson, 1967) and is now termed IgE, 
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(WHO, 1968). IgE is present in very small 
quantities in normal individuals, but levels 
of over 700 ng/ml, representing a 6 fold 
increase, were found in 63% of a series of 
patients with extrinsic allergic asthma by 
Johansson, in 1967. There are innumerable 
allergens that have been implicated in IgE 
mediated asthma. They include such com-
monly encountered substances in the en-
vironment as pollens, animal dander and 
fur, and the house dust mite, described by 
Voorhorst et a~ in 1964. 
Besides the well established evidence 
for the role of immediate Type I allergy in 
asthma, it now seems probable that the 
disease may also be initiated by hypersen-
sitivity mechanisms which do not involve 
reagin. Pepys in 1972 subdivided extrinsic 
asthma into atopic and non-atopic types. 
He has shown that precipitating, heat 
stable, antibodieS', which are complement 
dependent and known to .be important in 
Type III reactions, may play a part in 
asthma developing slowly over several 
hours, becoming maximal about .7 to 8 
hours after allergen exposure. In this type 
of extrinsic, non-atopic asthma it is the 
particular environmental exposure which 
is of primary importance, whereas in the 
Type I group it is the subject's constitution 
which is so. Late asthma of this tpe has 
ibe,Bllli ,aIsslocialted w,ibh Asq:>e11giUus ,fum,i'ga.tJus 
infection and has also been shown in bird 
fanciers using avian protein extracts and in 
workers exposed to enzymes extracted 
from Bacillus subl!~Us. ]jn ce,Doalin circum-
stances, e.g. bronchopulmonary aspergillo-
sis there may be a combination of Type I 
and Type III reaction. The patients when 
chaJ11e11lged Iw~tlh ,ex,tiraJcbs loif AspergiUus 
fum~gatus dJev,elLop ~mmeld1i:a!beaIirway ob" 
struction which rapidly resolves, only to 
recur after 4-5 hours, when it is more 
severe and persistent. 
Intrinsic asthma remains a very 
obscure form of the disease. There is no 
evidence in this form of asthmaI of any 
history of extrinsic allergy or a Type I 
allergic reaction to skin or inhalation tests. 
IgE levels in this group have been reported 
to be either normal or low. Blood eosino-
philia tends to be higher than in extrinsic 
type. 
Another type of asthma that cannot 
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strictly be included in the above classifica-
tion is Exercise induced asthma. In l;>at.ien~ 
suffering from this form of the disease, an 
attack of dyspnoea and wheezing come on 
some time after the patient has performed 
some kind of strenuous exercise. No satis-
factory explanation is as yet available for 
this form of asthma. 
(iii) Pharmacological mediators. 
In man, definite evidence is now avail-
able that histamine, slow reacting substan-
ce of anaphylaxis (SRS-A) and a third fac-
tor, eosinophil chemotactic-factor (ECF-A) 
described ,recently, (Kay and Austen, 
1971) are pharmacological mediators asso-
ciated with asthma. Up to now, no reports 
on the refease of kallikrein, bradykinin or 
5-hydroxytryptamine from antigen-stimu-
lated sensitized human tissue have been 
published; this is also true of the pros-
taglandins, El) E2 and F ziX. 
Histamine was shown to be released 
by an antigen-antibody reaction . from 
ihJumam iso~aited lIung by Schtlld et aL in 1951. 
There is still a great deal of controversy 
regarding . blood histamine levels in 
asthma. Porter & MitcheH (1970) have 
recently reported blood histamine levels, 
in asthmatic children which were signifi-
cantly higher .than in a control group. 
These levels fell to near normal in the 
asymptomatic period and during long-term 
steroid treatment. The significance of his-
tidine decarboxylase, the enzyme involved 
in the formation of histamine is still not 
sufficiefltly appreciated. It is known how-
ever that its activity can be very quickly 
increased as a result of stress and it is con-
ceivable that this might well be one of the 
mech,\n.isms involved in the triggering off 
of asthma during periods of particular 
stress. 
There is a great deal of indirect 
evidence indicating that SRS-A has a role 
to play in asthma, (Brocklehurst, 1960) 
although the importance or such a role has 
not as yet been definitely evaluated. It is 
known that the contraction due to SRS-A 
is very long lasting, much more than that 
produced by histamine.' All the evidence 
at present available seems to indicate that 
SRS-A is formed by enzymic processes 
activated by the union of antigen with 
reaginic antibody, whereas histamine is 
released from a pre-formed store. 
(Brocklehurst, 1970) 
(iv) Non-Immunological mechanisms. 
In addition to the immunological as-
pects of asthma it has been suggested that 
this condition may also be due to a 
functional imbalance of the autonomic ner-
vous system, a hypothesis first put forward 
by Eppinger and Hess in 1917. An impor-
tant advance in the study of the autonomic 
nervous system was made by Ahlquist in 
1948 who first suggested that the different 
pharmacological effects of adrenergic 
drugs on smooth muscle could be accounted 
for if one accepted the existence of two 
sets of receptors, which he designated 
alhpa and beta, in or near the target organs 
affected by these substances. Beta adrener-
gic action, as produced for example by iso-
prenaline, is associated with bronchial 
smooth muscle relaxation, myocardial 
stimUlation and peripheral vasodilation. 
Stimulation of alpha receptors is claimed 
to cause bronchoconstriction. The beta 
receptors were further subdivided into the 
Bl receptors which are concerned with the 
effects on the heart and the B2 receptors 
which are main~y associated wUh bronchial 
smooth muscle relaxation, 'by a group of 
workers led by ;Lands, in 1967. It is now 
generally believed that the B l'eceptor is 
an enzyme, adenyl cyclase. In 1968 Szenti-
vanyi proposed the theory that the major 
cause of bronchial hypersensitivity in 
asthma was a partial beta-adrenergic block-
ade. This theory is supported by the results 
of McNeill (1964) who reported that pro-
pranolol, a B adrenergic receptor blocking 
drug, reduced the vital capacity in asthma-
tics and that this was not reversed by 
isoprenaline. Similar effects have been 
,reported by Besterman and Friedlander 
(1965). 
McDonald and his co-workers (1967) 
showed that the effect of propranolol on 
asthmatics could be largely prevented by 
atropine and hence the bronchoconstriction 
could be explained on the basis of un-
0Ip,pos,edv;alg,a1l :acttvilty. F;LeiSh e,t aL :iJn 1970 
put forward the idea that the effect of 'beta 
blockers could be ascribed to their unmask-
ing alpha adrenergic receptor activity in 
bronchial smooth muscle. 
(v) Respiratory infection. 
Acute respiratory infections are often 
known to trigger off attacks in asthmatics. 
The cause of this altered reactivity is un-
known. There is some evidence suggesting 
a role for microbial products in the devel-
opment of bronchial hyperreactivity. Cooke 
(1947) reported attacks of asthma develop-
ing in asthmatic patients following injec-
tions of autogenous bacterial vaccine. 
Ouellette and Reed in 1965 noted thatasth-
matics were more sensitive to metacholine 
following an injection of killed influenza 
virus vaccine; normal subjects did not show 
this increase in sensitivity. Various micro-
bial products are known to fie able to 
reilease some of the pharmacological media-
tors of bronchoconstriction. The nature of 
such microbial activity is not known but it 
is presumed to oe a non-immunological 
direct effec.:t on such cells as the mast cells 
(Szentivanyi, 1971). 
(vi) Psychological factors. 
It has been :'I. long standing clinical 
observation that emotional factors and 
stress frequently precipitate attacks of 
wheezing in some asthmatic patients. 
Dekker and Green in 1956 showed that 
attacks of asthma could be regularly prod-
uced in some of their asthmatic patients 
through inducing anxiety by discussing 
with them emotionally charged situations 
derived from their case histories. In 1970, 
Zealley et a,~, investtgating psychopathology 
in asthmatics \\')ncluded that traits of sen-
sitivity, anxiety, obsession, dependency and 
low self confidence were commoner in 
these patients than in normal controls. 
They pointed out however, that psycho-
pathology need not be implicated as the 
cause of the asthmatic diathesis; it is as 
likely that concomitant psychopathology 
only determines the clinical presentation. 
It thus appears likely that these various 
factors contribute to a different degree 
and in a different manner in various pat-
ients and :act upon some final common 
,Path resulting in the clinical picture that 
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is so well known. 
Pathology 
Most of the knowledge at present 
available about the pathology of asthma 
has been obtained from lungs of patients 
dying in status asthmaticus. Little is known 
about the pathology of the less severe 
forms of asthma. However, important in-
formation has. also been yielded from 
bronchial biopsy material and sputum 
studies. One need hardly describe the 
gross aspects but at post mortem there 
are two striking featul"es. The lungs often 
appear over-distended and fail to: collapse 
and Gough (1955) likened them to the 
lungs in a case of fresh water drowning. 
The other outstanding finding in any 
section of an asthmatic lung is the presence 
of a dense exudation in the bronchial 
lumen. A detailed description of the chan-
ges present in the bronchial mucosa of 
patients dying in status asthmaticus has 
been given by Dunnm (1960). Salvato 
(1959, 1968) biopsied the bronchial wall 
of asthmatic patients before and during an 
asthmatic attack and found significantly 
lower mast cell counts in biopsy material 
removed from patients during an episode 
of asthma than in biopsy material obtained 
from the same patients during the 
asymptomatic phase of the disease. His 
findings were corroborated by the work of 
Connell (1971). It is suggested that the 
paucity of the mast cells is almost certain-
ly due to the fact that they are degranulat-
ed, and degranulated mast cells cannot be 
identified in tissue sections. It is weli 
known that degranulation of· mast cells 
occurs following anaphylaxis with' the 
liberation of such biologically active sub-
stances as histamine, heparin and most 
probably SRS-A. It seems likely that mast 
cell degranulation in asthma has the same 
functional significance. 
Connell (1971) also observed an in-
verse relationship between the eosinophi-
lic infiltrate present in asthma and the 
mast cell content of the bronchial wall; 
the greater the number of eosinophils, the 
fewer the number of mast cells. It is 
tempting to infer that in asthma the tissue 
eosinophilia 'is secondary to massive 
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degranulation of mast cells; it is known 
for instance that eosinophils appear in 
mastocytomas only when there is disrup-
tion of mast cells (West, 1959). Although 
it has been demonstrated that eosinophils 
are capable of phagocytosing antigen-
antibody complexes, little is actually known 
of their action in asthma, (Han~inger et al, 
1972) or of the inter-relationships between 
eosinophils and mast cells in this condition. 
One other striking feature in the 
pathology of asthma is the presence of 
marked hypertrophy of the bronchial 
muscle which was first described by Huber 
& Koessler in 1922. Dunnil'l et al, in 1969 
found that 12% of the segmental bronchial 
wall was occupied by smooth muscle in 
cases of status asthmaticus compared with 
4.6% in normals. The relative importance 
of bronchiai muscle hypertrophy and 
muscle contraction, mucosal oedema and 
congestion, increased mucus secretion and 
the obstruction of small bronchioles by 
tenacious mucus plugs in the pathogenesis 
of bronchial asthma is still a matter of 
some controversy (Ellul-Micallef, 1973). 
But although "bronchospasm" has long 
been regarded as an important if not the 
main, component of bronchial obstruction 
in asthma, there has been little direct 
proof of this. Frankland (1968) rightly 
makes a plea for the word "bronchospasm" 
not to be used in reference to asthma as 
its use would seem to indicate a precise 
knowledge of the pathogenesis of asthma 
which at present we do not have. The 
dominant role of smooth muscle contrac-
tion in the pathogenesis of asthma is now 
being questioned by various workers, as 
the importance of mucosal oedema, in-
creased mucus secretion and blocking of 
peripheral airways by tenacious mucus 
plugs is becoming increasingly more re-
cognised. Dunnill (1960, 1969) speculated 
that the smooth muscle hyperthrophy 
found in asthmatic lungs, where ciliary ac-
tion is often defective, w:as a response to 
increased clearance of exudate, possibly 
by a milking action; as suggested in the 
cineradiographic study of Holden & Arad-
ran (1957). 
It seems probable that in the earlier 
stages of an attack active broncho constric-
tion is the major factor, since dramatic 
relief is often obtained with sympathomi-
metic drugs, but when an acute attack 
becomes protracted or the condition 
becomes more chronic, the situation is 
complicated by mucosal oedema and by 
retention of very viscid mucus. 
Since it was established that corticos-
teroid therapy is frequently of benefit in 
asthma, it has been tempting to postulate 
that failure of the adrenal cortex may be 
an underlying defect in some patients. 
Recently there have been reports of asthma 
occurring in patients with Addison's 
disease and in one of these asthma appear-
ed to be the presenting symptom of adrenal 
insufficiency (Green and Lim, 1971, Harris 
and Collins, 1971). The infrequency of 
asthma in Addison's disease, variously 
reported as 0.5% (Maranon et al, 1956) 
and 4% (Carryer, 1960), however make 
the proposition most unlikely. Several 
papers on adrenal function in asthma have 
been published, some reporting inadequate 
basal function or inadequate response to 
stress and others finding no evidence at 
all of such dysfunction. Reviewing the 
evidence at present available in the 
literature, it seems fair to state that it 
appears that dysfunction of the hypothala-
mic-pituitary-adrenal axis is not a necessa-
ry predisposing factor for the develop-
ment of asthma. But one cannot exlude the 
possibility that it may well be a condition-
ing factor in some patients, although the 
relative infrequent occurrence of atopic 
diseases in patients with Addison's disease 
lends little support to this conjecture. 
Altered pulmonary function in asthma 
Increased airway resistance (Raw) 
may be said to be the physiological· hall-
mark of bronchial asthma. This increase 
in resistance to the flow of air is well 
reflected in the physiological indices used 
as tests in its detection and monitoring. In 
general the forced expiratory volume in 
one second (FEVJ ) and the maximum mid-
expirCl!tory flow rate (MM'FR) and peak 
expiratory flow rate (PEFR) are found to 
be consistently decreased from the predict-
ed and are usually well related to the 
severity of symptoms. The ratio of the 
FEVJFVC is also found to be reduced. 
However, it is now recognised that sub-
jective improvement is not always 
necessarily reflected in a similar change in 
the tests mentioned above. Raw as measur-
ed by body plethysmography provides a 
direct measurement of the resistance to 
the flow of air. Various studies using 
plethysmography have been carried out in 
asthmatic patients both during the sympto-
matic phase as well as following therapy. 
The Raw is always increased, frequently 
very considerably and the specific conduct-
ance (SGaw), that is, the conductance 
divided by the thoracic gas ,volume at 
which Raw is measured, correspondingly 
decreased during the acute phase, both 
indices returning towards normal values 
as the patient's condition improves (Pelzer 
and Thomson, 1969, EllubMicallef et al, 
1972). An increased airway resistance has 
been found to be present even during the 
asymptomatic phase in some asthmatics., 
(Bernstein & Kreindler, 1963). 
A number of reports have appeared in 
which measurements of total lung capacity 
(T.L.C.), functional residual capacity 
(F.R.C.) and residual volume (R.V.) in 
asthmatics were found to be elevated, thus 
reflecting the presence of a certain degree 
of hyperinflation. In general, the more 
severe the degree of airway obstruction 
the greater the amount of hyperinflation 
present, as shown by an elevated R.V. and 
F.R.C. and both indices tend to decrease 
following treatment. In some of the 
patients reported on by Woolcock & Read 
(1965) the F.R.C. during acute asthma was 
greater than the T.L.C. after recovery. In 
these patients tidal breathing during severe 
obstruction was taking place at a higher 
level than the point of maximal inspiration 
after recovery. Mead, Milic-Emili & 
Turner (1963) hold the view that'inhibit-
ing reflexes normally limit the degree of 
voluntary lung inflation; it this is true, then 
one must presume that such reflexes are 
modified in asthma. The vital capacity is 
generally decrease,d' in asthma and is 
usually more seVerely diminished the 
greater the degree of airway obstruction. 
Such a decrease in vital capacity' not in-
frequently persists in the asymptomatic 
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phase. Hyperinflation is not only present 
in the acute phase of the disease. Lung 
volumes have also been r.eported to be 
elevated in chronic asthma, returning to-
wards predicted normal values following 
corticoste~'oid therapy (Ellul-Micallef et al, 
1971>. 
The increase in F.R.C. may be compen-
satory to the decreased bronchial calibre 
found in asthma, and to a certain extent 
this may have a guy-rope effect in main-
taining the patency of the airways. This, 
however, is not obtained without consider-
able cost to the patient, for as the lung 
volume increases, compliance diminishes 
progressively so that the further inspir-
ation of a given volume of air will require 
the production of a higher transpulmonary 
pressure difference because the subject is 
breathing on a flatter part of the pressure-
volume curve. 
Various workers amongst whom are 
Gold et aJ (1967), Woolcock & Read (1968) 
and Finucane and Colebatch (1969) have 
reported a reduction in the lung elastic 
recoil pressure in asthmatics both during 
exacerbationsas well as in asymptomatic 
phases. The cause of the loss of elastic 
recoil of the lungs in asthma is unknown. 
The lung elastic recoil pres~ure is depen-
dent on two factors: the tension exerted by 
surfactant and the elastic properties of 
pulmonary tissue. In emphysema the fibre 
network making up the pulmonary tissue 
is disrupted and elastic retraction of the 
lung would be expected to be, and is, in 
fact, reduced. In asthma hO\,vever, this 
network is intact and hence Qther factors 
must be responsible for the loss of elastic 
recoil. It has been suggested that prolonged 
distension of the connective tissue of the 
lungs causing temporary structural deform-
ation is a possible explanation. Another 
alternative that has been put fOL'Ward is 
that the change could be related to the 
forces exerted by surfactant. There is how-
ever very little evidence to support either 
possibility. 
One other parameter that is causing 
a lot of controversy in asthma is the pul-
monary diffusing capacity. (Tco) Over the 
past five years a number of papers have 
appeared in which this has been found to 
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be decreased (Palmer and Diament, 1969, 
1970; Levine et aL, 1970). Results by equal-
ly reliable workers have shown the Tco to 
be remarkably normal (McFadden & 
Lyons, 1968; Daly, 1971). The difficulty in 
sorting out the apparent discrepancy of the 
diffusion capacity values in asthma 
obtained by various workers can be 
ascribed to three main factors: patient 
selection, variation in degree of airway 
obstruction and differences in technique. 
Thus there is not infrequently difficulty 
when selecting patients, in differentiating 
between those suffering from asthma and 
those with chronic bronchitis with a 
degree of emphysema. However, the inter-
pret:ation of reports of Tco in asthma is 
perhaps most seriously hampered by the 
variety of methods used in its determin-
ation. It is obvious that each method 
measures something different and probably 
none measures the true diffusing capacity 
of the 'pulmonary membrane'. The transfer 
of gas in asthma thus appears to be more 
impeded by failure to deliver inspired gas 
to the alveolar surface than by interference 
with diffusion through the 'pulmonary 
membrane' as happens in pulmonary 
fibrosis or emphysema. 
Very little attention was paid to 
changes that occur in blood gases during 
asthma until comparatively recently. Bates 
and Christie in 1964 stated that "the 
patient with moderately severe bronchos-
pasm but not in status asthamaticus only 
rarely shows any signi,ficant abnormality 
of arterial oxygen saturation of CO 2 
tension". It had been generally assumed 
that the PaCO z is usually normal or low, 
due to hyper ventilation, until the terminal 
stages of status asthmaticus, when the 
PaCO. rises rapidly and respiratory failure 
supervenes. Tai and Read in 1967 were the 
first to report CO2 retention with PaCO z 
values ranging up to 200 mmHg and 
marked respiratory acidosis with a blood 
pH as low as 6.81, in twelve patients in 
status asthmaticus admitted to their care. 
Their data showed that in other patients 
with only moderate clinical severity con-
siderable hypoxaemia could also be 
present. Similar results have now been 
reported by a number of different workers. 
They found a general correlation between 
the degree of reduction of the FEV 1 and 
the extent of disturbance of blood gas 
tensions in patients with moderately severe 
asthma. They pointed out that FEV1 levels 
of less than 1 litre were especially associat-
ed with a significant reduction of arterial 
PO z; at the same time they emphasized that 
the correlation was not good enough to 
make FEV 1 leve'ls greater than a litre a 
reliable index of a fairly normal PaO •. The 
same conclusion was reached by Rees et aL 
in 1968, who stated that since increases in 
FEV1 were not always accompanied by a 
rise in PaO., such changes could not be 
relied upon to indicate improved oxygen-
ation. Rees, Miliar & Donald in 1968, fol-
lowed the dinical course and arterial blood 
gas tensions of 24 patients in status 
asthmaticus and found that hypoxaemia 
was invariably present, was frequently 
quite marked and persisted despite in-
tensive therapy sometimes for weeks. Most 
patients were normocapnic 01' even hypo-
capnic. When severe hypercapnia was 
present the patients generally died. They 
found that the pulse rate correlated well 
with PaOz and in the severely hypoxaemic 
patients the frequency exceeded 130 beats/ 
min. It is now generally accepted that 
hypoxaemia, often of a dangerous degree, 
may be present in asthmatic patients, and 
that severe hypercapnia is not usually pre-
sent except terminally. When the PaCOz is 
high this is usually of grave prognostic 
significance. The accompanying distur-
bance in acid-base balance as reflected in 
the arterial blood, shows that hypercapnia 
in most of these patients probably develops 
acutely. Chronic elevation of PaC02 is 
relatively uncommon in asthma - the 
converse of what occurs in chronic 
bronchitis. 
The increased renal reabsorption of 
bicarbonate, which is an impc~tant defence 
against respiratory acidosis both in adults 
and in children thus appears to be too slow 
a mechanis'm ,to be of great importance in 
acute asthma, in which dangerous hyper-
capnia may develop very acutely. Mithoefer 
et aL (1968) have found that correction of 
the respiratory acidosis by infusion of 
sodium bicarbonate was valuable in treat-
ing intractable asthma, but others seem to 
have had less success with this approach 
(Flenley, 1971). The mechanism of hypo-
xaemia with or without CO2 retention 
implies a maldistribution of ventilation and 
perfusion in the lungs which is shown by 
an elevated alveolar to arterial oxygen 
tension difference, (A-aW02 , and higher 
than normal dead space-tidal volume ratios 
(VD /VT). Elevated values for (A-a) D02 
and VD/VT have now been shown to be 
present both during the acute attack 
(Field, 1967), in chronic asthma (Ellul-
Micallef, 1972) as well as during the 
asymptomatic phase (Levine et aL, , 970) . 
Conclusion 
Although no agreement has yet been 
reached on a final definition of asthma, 
(Working Group on the Definition Of 
Asthma, 1971) none would contest that the 
main pathophysiological hallmark of this 
disease is an increase in airway resistance 
to the flow of air due to widespread nar-
rowing of the airways. The actual site of 
such narrowing is still a matter of some 
controversy (Ellul..,Mical'lef, 1972b, Bain-
bridge et al, 1973). Hyperinflation fre-
quently occurs and it has now become 
widely recognized that this may be present 
when the more common spirometric in-
dices used for detecting airway narrowing 
are normal, indicating an attempt on the 
part of the asthmatic patient to overcome 
the obstruction present by breathing at a 
higher lung volume. Further research is 
necessary to elucidate ,the precise nature 
of the changes in lung elastic recoil and 
transfer factor that have been reported in 
asthma. Blood gas changes in this disease, 
often of a severe nature, are now an 
established fact and appear to be mainly 
due to VA/Q abnormalities. The aetiology 
and pathogenesis of this condition as has 
been shown is still far from clear and a lot 
of wor kstilJ remains to be done to try and 
unravel this problem. Bearing all this in 
mind it is perhaps not surprising that treat-
ment for asthma is anything but satis-
factory, even in centres which have been 
specifically set up to deal with it. 
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The British MedicaiJ. Association 
(Malta Branch) prize in the medical essay 
competltioll for 1972 was awarded to 
Dr. Paul Cassar for this paper. 
Some years ago I stated that a Chair 
of Midwifery was set up in our University 
in 1833 but that the subject was already 
being taught since 1802 by the Lecturer in 
Obstetrics at the Women's Hospital in 
Calletta (Cassar, 1965a). 
The document 
I have now come across a document 
which not only confirms that midwifery 
was being taught to medical students in 
the very early years of the 19th century but 
which also gives us a picture of the state 
of midwifery at that period. The discovery 
of this document is worth recording as it 
furnishes us with the earUest "textbook" 
of midwifery known to have been used in 
our medical school. 
It consists of a manuscript volume 
containing the series of lectures delivered 
in Italian by the teacher of obstetrics at the 
Civil Hospital of Valletta, of which the 
Women's Hospital formed part. This 
manuscript belonged to the medical 
student (later Doctor) Salvatore Bardon 
who qualified M.D. in Malta in 1818. It 
!beams luhe Itib],fe:- Trattato deU'arte ostetrica 
dettato e spiegctto dal PeriJble Signor Dr. 
Francesco Butngiec (sic) neUo Studio Publi-
co del Grand'Ospedale Nazionalede' MaUe-
si. Principiato li 18 ottobre 1804. (Til"eatise 
on the Art of Obstetrics dictated and 
explained by the Most Illustrious Dr. 
Francesco BUtigiec in the Public Study of 
the National Grand Hospital of the Maltese. 
Commenced on the 18th October 1804). 
(Fig. 1). It comprises sixty-five TitoU or 
chapters totalling 247 folios (31 cm. x 21 
cm.) with another three folios listing the 
contents or titles of each chapter. 
The subject matter covers the differ-
entaspects of obstetrics very comprehen-
sively and ranges from the detailed 
anatomy of the pelvis with its various 
organs and of the gravid uterus; the clinic-
al signs of pregnancy; abortion; normal and 
abnormal labour; management of the 
puerperium; twins and superfoetation; 
manual correction of the various mal-
positions;, the use of instruments and the 
performance of Caesarean section in the 
